- Xavier Prats Monné has been named as health director general of the European Commission. He will be the first permanent director general of the health and food safety directorate since Paola Testori Coggi resigned in October 2014 following a breach of tender policy. Xavier was previously director general of the education and culture directorate.
- Viv Rees has joined Ashfield Insight & Performance as performance director, working alongside Mark Pringle and Charlotte Crowe. Viv will focus on delivering leadership, team and individual training and development. She has more than twenty years of experience in pharma with Merck and Lundbeck, more than half of this time dedicated to learning and development. Earlier this year, Viv won the Learning and Development Professional category at the 2015 Pf Awards.
- Specialist medical education company Wave has appointed Mehwish Abdeali to their team as senior programme executive. Mehwish joins Wave from CircleReading Hospital, where she was primary care manager with additional responsibility for business development. She brings extensive experience in organising medical educational events for healthcare professionals in a range of therapeutic areas.
- Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans CBE CEng as non-executive chairman. John held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, and Johnson & Johnson. An advisor to public and third sector organisations, he was appointed by the prime minister in 2014 as the UK government’s life science champion for medical technology. He was awarded a CBE for services to life sciences, healthcare and science in 2012.
- Avacta Group, a global provider of proprietary diagnostic tools, consumables and reagents for life sciences, has appointed Dr Mike Owen to its board as a non-executive director. Dr Owen was senior vice president and global head of research of the biopharmaceuticals R&D unit at GlaxoSmithKline until 2010, when he left to establish monoclonal antibody specialist Kymab.
- Full service outsourcing and resourcing company Star – part of the Uniphar Group – has welcomed Phil Tomlinson, David Bournes and Dave Faulkner to its leadership team. Phil Tomlinson joins Star Outsourcing as business development director and David Bournes as business development manager; both are focused on delivering tailored solutions for Star’s outsourcing clients in the UK. Dave Faulkner joins as general manager of Star’s new outsourcing and resourcing team in Ireland.
- James Bradner will succeed Mark Fishman as president of the Novartis Institutes for BioMedical Research (NIBR) effective March 1, 2016. James, a scientist from Dana-Farber Cancer Institute and Harvard Medical School, will be based at NIBR's global headquarters in Cambridge, Massachusetts and report to CEO Joseph Jimenez.
- Astellas has promoted Eugene Van Rensburg to chief financial officer for its EMEA division. Eugene, who has over 15 years of international industry experience, was previously senior finance director. He succeeds Niek Stander, who is now managing director of the company’s German business.
- Andy Grigg has joined Bedrock Healthcare Communications as head of medical communications. Andy joins from Inspired Science where he was practice director. A PhD scientist, he started his career at GSK within the clinical safety and pharmacovigilance, before joining agency life initially in medical writing.
- Alligent Biopharm Consulting’s two principals, Joe Kohles and David Thompson, will be joining the Envision Pharma leadership team after Envision’s acquisition of the company. Kohles and Thompson said: “We are delighted to join the Envision Pharma Group. Our focus on medical strategy, coupled with Envision’s global presence and technology leadership position, offers the potential for us to expand and enrich our service breadth and offering.”
- Recently-established EUSA Pharma has named William Crouse to its board of directors. William brings 50 years’ experience in the life sciences industry, most recently as a general partner at Healthcare Ventures, one of the world’s largest venture capital firms specialising in biotechnology. Previously, he was worldwide president of Ortho Diagnostic Systems and a vice-president of Johnson & Johnson International.
- Adelphi Research UK has made six new appointments. Amanda Heselwood and Kristian Barker have both been named as associate directors. Amanda began her healthcare career with Adelphi in 2006 and Kris joined the company in 2014. Meanwhile, RJ Lally and Helen Service have joined the team as senior research executives, and Deana Scott and Christian Atkinson have joined as research executives.
- PureTech has recruited Michael MacLean as chief financial officer and executive vice president. Michael joins PureTech from Iron Mountain, where he was CFO of its North American business, overseeing $2.2 billion of annual revenue. Previously, he was senior vice-president, finance and chief accounting officer at Biogen.